3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve the Unaudited Standalone and ....
3BBLACKBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
3B BlackBio Dx Ltd has informed BSE that its Board of Directors will meet on Thursday, 13 November 2025 at 3:00 p.m. at the registered office in Bhopal. The agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30 September 2025 (Q2 FY26 and H1 FY26). The company has also noted that the insider trading window has been closed since 1 October 2025 and will reopen 48 hours after the results are declared on 13 November.
This is a routine regulatory intimation with no actual numbers disclosed yet. Investors should watch the 13 November announcement for the unaudited Q2/H1 FY26 results, which could move the stock depending on performance versus expectations.